tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market
CHRS
Coherus Biosciences
RESEARCH TOOLSreports
Want to see CHRS full AI Analyst Report?

Coherus Biosciences (CHRS) Income Statement

1,661 Followers

Coherus Biosciences Income Statement

Last quarter (Q4 2025), Coherus Biosciences's total revenue was $12.75M, a decrease of -76.46% from the same quarter last year. In Q4, Coherus Biosciences's net income was $-37.64M. See Coherus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 42.17M$ 266.96M$ 257.24M$ 211.04M$ 326.55M
Gross Profit
$ 28.36M$ 149.41M$ 98.25M$ 140.96M$ 268.96M
Operating Expenses
$ 209.49M$ 261.07M$ 301.45M$ 397.84M$ 532.82M
Depreciation and Amortization
$ 3.92M$ 5.28M$ 3.79M$ 3.70M$ 3.45M
EBITDA
$ -170.20M$ 60.94M$ -193.94M$ -255.58M$ -260.69M
Operating Income
$ -181.13M$ -111.67M$ -203.20M$ -256.88M$ -263.86M
Other Income/Expenses
$ -1.99M$ 140.17M$ -35.07M$ -34.87M$ -23.24M
Pretax Income
$ -183.12M$ 28.51M$ -238.27M$ -291.75M$ -287.10M
Net Income
$ -170.29M$ 28.51M$ -237.89M$ -291.75M$ -287.10M
Per Share Metrics
Basic EPS
$ -1.45$ 0.25$ -2.53$ -3.76$ -3.81
Diluted EPS
$ -1.45$ 0.25$ -2.53$ -3.76$ -3.81
Weighted Average Shares Outstanding
 120.37M 114.55M 94.16M 77.63M 75.45M
Weighted Average Shares Outstanding (Diluted)
 120.37M 114.83M 94.16M 77.63M 75.45M
Currency in USD

Coherus Biosciences Earnings and Revenue History